Page last updated: 2024-08-05 15:50:27

nonnucleoside hepatitis C virus polymerase inhibitor

Any inhibitor of nonnucleoside hepatitis C virus polymerase.

ChEBI ID: 85180

Members (1)

MemberDefinitionClass
abt-333A member of the class of pyrimidone, which is (as the monohydrate of its sodium salt) in combination with ombitasvir, paritaprevir and ritonavir (under the trade name Viekira Pak) for treatment of chronic hepatitis C virus genotype 1 infection as well as cirrhosis of the liver.dasabuvir

Research

Studies (211)

TimeframeStudies, Drugs with This Role(%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's178 (84.36)24.3611
2020's33 (15.64)2.80

Study Types

Publication TypeStudies, Drugs with this Role (%)All Drugs (%)
Trials46 (20.44%)5.53%
Reviews32 (14.22%)6.00%
Case Studies24 (10.67%)4.05%
Observational18 (8.00%)0.25%
Other105 (46.67%)84.16%

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)Drugs
Spike glycoproteinSevere acute respiratory syndrome-related coronavirusPotency5.011911

Inhibition Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)Drugs
Protein cereblonHomo sapiens (human)IC5015.600011
Protein cereblonHomo sapiens (human)Ki4.710011

Activation Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)Drugs
RNA-directed RNA polymerase EC500.001811